Fundraising Fox

Autonomy

San Francisco, US · 4 known investors

Autonomy Bio is a biotech company developing drugs targeting human aging to extend healthy lifespan.

BiotechLongevity

Investors · 4

age1✓ verifiedSan Francisco · $500K – $4M
Valhalla VenturesNew York · $10M
Kleiner PerkinsreportedMenlo Park · $500K – $15M
SoftBank GroupreportedTokyo

In the news

Smack Raises $61 Million To Expand Scope Of Edge Autonomy Platform - Defense Dailydefensedaily.com · Aug 2026Reshaping the Physical World: Gravis Robotics Raises $200M for Construction Autonomy | RoboticsTomorrowroboticstomorrow.com · Aug 2026Inner Logic Raises $11.5M Seed Round to Build Autonomy-Enabling Infrastructure for Procedural Devicestheaiinsider.tech · Aug 2026Reliable Robotics Raises $160M to Advance Autonomy Systemgovconwire.com · Apr 2026Maritime Autonomy Company Saronic Raises $1.75B in Series D Funding Round - GovCon Wiregovconwire.com · Apr 2026

Frequently asked questions

What does Autonomy do?
Autonomy Bio is a biotech company developing drugs targeting human aging to extend healthy lifespan.
Who are Autonomy's investors?
Autonomy's investors include age1, Valhalla Ventures, Kleiner Perkins, SoftBank Group.
Where is Autonomy headquartered?
Autonomy is headquartered in San Francisco, US.